Atıf Formatları
FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. KÖKEN AVŞAR Et Al. , "FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE," Annual European Congress of Rheumatology, EULAR 2019 , vol.78, Madrid, Spain, pp.993-994, 2019

KÖKEN AVŞAR, A. Et Al. 2019. FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE. Annual European Congress of Rheumatology, EULAR 2019 , (Madrid, Spain), 993-994.

KÖKEN AVŞAR, A., GERCİK, Ö., CAN, G., ZENGİN, B., KOCAER, S. B., KILIÇ, A. O., ... USLU, S.(2019). FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE . Annual European Congress of Rheumatology, EULAR 2019 (pp.993-994). Madrid, Spain

KÖKEN AVŞAR, AYDAN Et Al. "FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE," Annual European Congress of Rheumatology, EULAR 2019, Madrid, Spain, 2019

KÖKEN AVŞAR, AYDAN K. Et Al. "FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE." Annual European Congress of Rheumatology, EULAR 2019 , Madrid, Spain, pp.993-994, 2019

KÖKEN AVŞAR, A. Et Al. (2019) . "FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE." Annual European Congress of Rheumatology, EULAR 2019 , Madrid, Spain, pp.993-994.

@conferencepaper{conferencepaper, author={AYDAN KÖKEN AVŞAR Et Al. }, title={FRI0596 AZATHIOPRINE AND GLUCOCORTICOID COMBINATION MIGHT BE A GOOD TREATMENT OPTION TO ACHIEVE REMISSION IN PATIENTS WITH IGG4-RELATED DISEASE}, congress name={Annual European Congress of Rheumatology, EULAR 2019}, city={Madrid}, country={Spain}, year={2019}, pages={993-994} }